Bayer shares rally; €3 bn Apollo LARC boost

Timeline

1. about 19 hours ago

   [BUSINESS] 6 sources

   Bayer posts strong Q2 earnings and raises outlook amid glyphosate lawsuit

   Bayer beats Q2 expectations with €219 million profit and raises outlook despite a glyphosate lawsuit; SAP launches €344 million buyback as cloud sales surge; Merck lifts 2026 revenue target but cuts EPS after T

2. 23 days ago

   [BUSINESS] 6 sources

   Bayer triumphs in US Supreme Court glyphosate case as pesticide approvals broaden

   The US Supreme Court limited lawsuits against Bayer over Roundup glyphosate, boosting its shares, as the company also consolidates its business and secures new pesticide approvals.

3. 25 days ago

   [BUSINESS] 2 sources

   Bayer shares surge after US Supreme Court clears glyphosate liability

   US Supreme Court cleared Bayer of glyphosate liability, sending its shares up ~20% and up 81% over a year, though the rally now steadies amid pending lawsuits.

4. 26 days ago

   [BUSINESS] 10 sources

   Bayer secures €3 billion from Apollo to fund contraceptives unit

   Bayer raises €3 billion from Apollo, selling a minority stake in its LARC contraceptives unit while keeping majority control, to boost liquidity amid Roundup litigation costs.

5. 27 days ago

   [BUSINESS] 2 sources

   U.S. Supreme Court blocks state Roundup warnings, reshaping pesticide lawsuits

   The Supreme Court barred state‑required Roundup warnings, altering pesticide litigation, while a North Carolina jury found an Uber driver liable for battery in ongoing multidistrict litigation.

6. 29 days ago

   [HEALTH] 3 sources

   U.S. Supreme Court Limits State Laws on Roundup Herbicide Labeling

   The Supreme Court’s 7‑2 ruling blocks state failure‑to‑warn suits over EPA‑approved Roundup labels, a win for Bayer‑Monsanto. Lawmakers have introduced the People Over Poison Act to restore labeling warnings.

7. 29 days ago

   [BUSINESS] 3 sources

   Bayer shares jump after US Supreme Court curtails glyphosate lawsuits and analysts lift price targets

   US Supreme Court limits Bayer glyphosate lawsuits; analysts raise price targets to €55‑60, boosting shares above €50 as the firm plans a U.S. spin‑off.

8. about 1 month ago

   [BUSINESS] 2 sources

   Bayer and TKMS Stocks Jump on Legal Wins and Technical Gains

   Bayer’s shares double amid overbought signals and major legal moves, including a $7.25 bn Roundup settlement delay, while German defence firm TKMS climbs 11 % as technical indicators turn bullish.

9. about 1 month ago

   [BUSINESS] 2 sources

   US Supreme Court blocks state‑law cancer warnings in Roundup case

   The U.S. Supreme Court ruled that federal pesticide law bars state‑law cancer‑warning claims against Bayer’s Roundup, halting thousands of lawsuits and reducing the company’s liability.

10. about 1 month ago

    [BUSINESS] 3 sources

    Bayer shares jump 191% since April, analysts set modest price targets

    Bayer’s shares have climbed about 191 % since April 2025, hitting key resistance levels. Analysts (8 buy, 3 hold) set an average target of €49.23 versus a current price of €48.41, noting mixed technical signals

11. about 1 month ago

    [BUSINESS] 9 sources

    Bayer restructures US glyphosate business into Ruveon unit and seeks tariffs on Chinese imports

    Bayer created the Ruveon unit to run its U.S. glyphosate business and filed a petition for antidumping duties on Chinese imports, prompting farmer opposition.

12. about 1 month ago

    [BUSINESS] 13 sources

    Bayer/Monsanto Shielded from Roundup Cancer Lawsuits by US Supreme Court

    US Supreme Court ruled 7‑2 that federal law blocks state Roundup cancer lawsuits, shielding Bayer/Monsanto and prompting Bayer to seek tariffs on Chinese glyphosate, sparking farmer opposition.

13. about 1 month ago

    [BUSINESS] 9 sources

    Bayer shares surge after US Supreme Court blocks glyphosate warning lawsuits

    The U.S. Supreme Court ruled 7‑2 that federal law preempts state glyphosate warning claims, shielding Bayer’s Roundup. Bayer shares jumped up to 23 % as analysts lifted targets, though existing settlements and债

14. about 1 month ago

    [BUSINESS] 2 sources

    U.S. Supreme Court bars state cancer warnings for Roundup pesticide

    The Supreme Court ruled 7‑2 that federal pesticide law preempts state cancer‑warning lawsuits against Monsanto’s Roundup, keeping EPA‑approved labeling in place.

15. about 1 month ago

    [BUSINESS] 2 sources

    German court upholds ruling against Bayer's misleading net‑zero pledge

    A Cologne court upheld DUH's ruling that Bayer’s net‑zero pledge was misleading, ordering a stop to deceptive climate ads and demanding transparent reporting and a glyphosate exit.

16. about 1 month ago

    [BUSINESS] 2 sources

    Bayer shares rise as US Supreme Court limits glyphosate liability

    Bayer stock climbs after the US Supreme Court limits glyphosate liability; Jefferies raises the target price to €46 but maintains a hold rating.

17. about 1 month ago

    [BUSINESS] 78 sources

    Bayer Wins U.S. Supreme Court Ruling Blocking Thousands of Roundup Lawsuits

    The Supreme Court ruled that federal law preempts state claims over Roundup labeling, overturning a $1.25 M verdict and blocking thousands of lawsuits; Bayer hailed the decision, while health advocates decried​

18. about 1 month ago

    [HEALTH] 2 sources

    U.S. Supreme Court Shields Pesticide Makers from Roundup Cancer Lawsuits

    The Supreme Court ruled that federal law preempts state cancer lawsuits against Bayer and other pesticide makers over Roundup, shielding them from liability and prompting calls for congressional action.

19. about 1 month ago

    [BUSINESS] 2 sources

    Bayer confronts €5 bn glyphosate legal burden as it launches AI drug‑discovery partnership

    Bayer faces €5 bn glyphosate legal costs while expanding in China and launches an AI drug‑discovery partnership with U.S. firm Iambic Therapeutics.

20. about 2 months ago

    [BUSINESS] 2 sources

    Bayer secures FDA approval for two MRI contrast agents as US glyphosate lawsuit hurdle is cleared

    Bayer got FDA approval for two MRI contrast agents and a US judge cleared a procedural hurdle in its $7.25 bn glyphosate lawsuit, boosting the stock.

21. about 2 months ago

    [BUSINESS] 2 sources

    Bayer and Adidas stocks react to legal battles and World Cup boost

    Bayer shares stabilize modestly amid U.S. glyphosate lawsuits, while Adidas gains on strong earnings and World Cup prospects, with analysts targeting €40.5 and €211 respectively.

22. 2 months ago

    [BUSINESS] 4 sources

    Bayer adopts new legal tactics in US glyphosate lawsuits ahead of Supreme Court ruling

    Bayer files new motions to shift US glyphosate lawsuits to Missouri court and braces for a Supreme Court decision, calling the outcome business‑decisive; shares rise 1.5%.

23. 2 months ago

    [BUSINESS] 2 sources

    Bayer faces US court shift as EU pesticide reforms spark health concerns

    Bayer's glyphosate settlement faces a June opt‑out deadline and a US court move to San Francisco, while the German Leopoldina warns EU plans to loosen pesticide approvals could endanger health.

24. 3 months ago

    [HEALTH] 2 sources

    Glyphosate Herbicide Faces Health Scrutiny as Homegrown Weed Control Gains Attention

    Glyphosate's cancer risk sparks lawsuits and home‑grown weed‑killer alternatives.

25. 3 months ago

    [BUSINESS] 5 sources

    Bayer's Roundup lawsuits face Supreme Court challenge and contested Missouri settlement

    Bayer's Roundup faces a Supreme Court immunity challenge and a disputed $7.25 B Missouri settlement, with judges questioning future claim coverage.

26. 3 months ago

    [HEALTH] 4 sources

    US Supreme Court weighs limits on glyphosate lawsuits over Roundup cancer claims

    US Supreme Court weighs federal preemption in glyphosate cancer lawsuits against Roundup.